Yang Duan

Dr. Yang Duan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SCShannan Chen
Shannan Chen
JDJinfeng Duan
Jinfeng Duan
HWHong Wang
Hong Wang
RWRongqiang Wang
Rongqiang Wang
JLJinze Li
Jinze Li
SQShouliang Qi
Shouliang Qi

1 December 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
ZXZhihua Xu
Zhihua Xu
LSLingling Sun
Lingling Sun
YDYang Duan
Yang Duan
JZJinghua Zhang
Jinghua Zhang
MZMengzhi Zhang
Mengzhi Zhang
XCXiaonan Cai
Xiaonan Cai

6 September 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SCShannan Chen
Shannan Chen
JDJinfeng Duan
Jinfeng Duan
NZNan Zhang
Nan Zhang
MQMiao Qi
Miao Qi
JLJinze Li
Jinze Li
SQShouliang Qi
Shouliang Qi

1 December 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
ZXZhihua Xu
Zhihua Xu
FLFangfei Li
Fangfei Li
BWBing Wang
Bing Wang
DXDengxiang Xing
Dengxiang Xing
YPYusong Pei
Yusong Pei
YDYang Duan
Yang Duan
Objective: To assess the suitability of deep medullary vein visibility in susceptibility weighted imaging—magnetic resonance imaging studies as a method for the diagnosis and evaluation of cerebral small vessel disease progression.Methods: A total of 92 patients with CSVD were enrolled and baseline clinical and imaging data were reviewed retrospectively. Neuroimaging biomarkers of CSVD including high-grade white matter hyperintensity (HWMH), cerebral microbleed (CMB), enlarged perivascular space (PVS), and lacunar infarct (LI) were identified and CSVD burden was calculated. Cases were grouped accordingly as mild, moderate, or severe. The DMV was divided into six segments according to the regional anatomy. The total DMV score (0–18) was calculated as the sum of the six individual segmental scores, which ranged from 0 to 3, for a semi-quantitative assessment of the DMV based on segmental continuity and visibility.Results: The DMV score was independently associated with the presence of HWMH, PVS, and LI (P < 0.05), but not with presence and absence of CMB (P > 0.05). Correlation between the DMV score and the CSVD burden was significant (P < 0.05) [OR 95% C.I., 1.227 (1.096–1.388)].Conclusion: The DMV score was associated with the presence and severity of CSVD.

13 October 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
LZLuojin Zhang
Luojin Zhang
JLJinze Li
Jinze Li
ZWZhenguo Wang
Zhenguo Wang
WLWei Li
Wei Li
XWXinrui Wang
Xinrui Wang
YDYang Duan
Yang Duan
Background and purpose: Malignant brain edema (MBE) occurring after mechanical thrombectomy (MT) in acute ischemic stroke (AIS) could lead to severe disability and mortality. We aimed to investigate the incidence, predictors, and clinical outcomes of MBE in patients with AIS after MT. Methods: The clinical and imaging data of 155 patients with AIS of anterior circulation after MT were studied. Standard non-contrast CT was used to evaluate baseline imaging characteristics at admission. Clinical outcomes were measured using the 90-day modified Rankin Scale (mRS) score. Based on the follow-up CT scans performed within 72 h after MT, the patients were classified into MBE and non-MBE group. MBE was defined as a midline shift of ≥ 5 mm with signs of local brain swelling. Univariate and multivariate regression analyses were used to analyze the relationship between MBE and clinical outcomes and identify the predictors that correlate with MBE. Results: MBE was observed in 19.4% of the patients who underwent MT and was associated with a lower rate of favorable 90-day clinical outcomes. Significant differences were observed in both MBE and non-MBE groups: baseline Alberta Stroke Program Early CT (ASPECT) score, hyperdense middle cerebral artery sign (HMCAS), baseline signs of early infarct, angiographic favorable collaterals, number of retrieval attempts, and revascularization rate. Multivariate analysis indicated that low baseline ASPECT score, absent HMCAS, angiographic poor collaterals, more retrieval attempt count, and poor revascularization independently influenced the occurrence of MBE in AIS patients with anterior circulation after MT. Conclusion: MBE was associated with a lower rate of favorable 90-day clinical outcomes. Low baseline ASPECT score, absent HMCAS, angiographic poor collaterals, more retrieval attempt count and poor revascularization were independently associated with MBE after MT.

25 October 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
ZXZhihua Xu
Zhihua Xu
FLFangfei Li
Fangfei Li
DXDengxiang Xing
Dengxiang Xing
HSHongyan Song
Hongyan Song
JCJingshu Chen
Jingshu Chen
ZWZhenguo Wang
Zhenguo Wang
Objective: To explore the biomarkers of cerebral small vessel disease (CSVD) associated with cognitive impairment.Methods: A total of 69 patients with CSVD were enrolled in the study, and baseline clinical and imaging data were reviewed retrospectively. The following neuroimaging biomarkers of CSVD were identified: high-grade white matter hyperintensity (HWMH), cerebral microbleeds (CMB), enlarged perivascular space (PVS), and lacunar infarct (LI). A total score for CSVD was calculated. The deep medullary veins (DMVs) were divided into six segments according to the regional anatomy. The total DMV score (0–18) was derived from the sum of the scores of the six individual segments, the scores of which ranged from 0 to 3, for a semiquantitative assessment of the DMV that was based on segmental continuity and visibility.Results: The DMV score, patient age, and total CSVD score were independently associated with the presence or absence of cognitive impairment in patients with CSVD (P < 0.05). By integrating patient age and the total CSVD and DMV scores, the area under the curve of the receiver operating characteristic curve (AUROC) for predicting CSVD associated with cognitive impairment was 0.885, and the sensitivity and specificity were 64.71 and 94.23%, respectively.Conclusions: The DMV score may be a novel imaging biomarker for CSVD associated with cognitive impairment. The integration of the DMV score with age and total CSVD score should increase the predictive value of the DMV score for CSVD associated with cognitive impairment.